Source: Citybizlist

Evelo: Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights

CAMBRIDGE, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) - Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a... Read MoreThe post Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights appeared first on citybiz.

Read full article »

Evelo's Competitors | Evelo's News | Evelo's Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

25-100

President & CEO

Balkrishan Gill

CEO Approval Rating

89/100

Evelo is a Massachusetts-based biotechnology company that researches and develops oral medicines for the treatment of patients with inflammatory diseases.